4-Phenylbutyric acid (4-PBA, Benzenebutyric acid) is a histone deacetylase (HDAC) inhibitor and a key epigenetic inducer of anti-HCV hepatic hepcidin. 4-Phenylbutyric acid inhibits LPS-induced inflammation through regulating endoplasmic-reticulum (ER) stress and autophagy in acute lung injury models.
4-PBA inhibits the ER stress induced by SiNPs in RAW264.7 cells, as evidenced by the expansion and degranulation of ER, as well as greatly up-regulated Bip and CHOP expressions.[3]
4-PBA attenuates LPS-induced bone loss in lipopolysaccharide (LPS)-treated mice, by increasing area of TRAP-positive osteoclasts (OCs) and serum level of collagen type I fragments.[4]
4-苯基丁酸(4-PBA,苯丁酸)是组蛋白去乙酰化酶(HDAC)抑制剂,也是促进抗HCV肝细胞铁调蛋白表达的关键表观遗传诱导剂。4-苯基丁酸通过调节内质网应激和自噬,在急性肺损伤模型中抑制LPS诱导的炎症。
4-苯基丁酸抑制SiNPs诱导的RAW264.7细胞内质网应激,表现为内质网的扩张和脱颗粒化,以及Bip和CHOP表达的显著上调。[3]
4-苯基丁酸通过增加TRAP阳性成骨细胞(OCs)面积和血清胶原I片段水平,减轻了LPS处理小鼠骨丢失的程度。[4]
[1] Kiyoon Kim, et al. Int J Mol Sci. 2020 Aug 1;21(15):5516. [2] Meichun Zeng, et al. Toxicol Lett. 2017 Apr 5;271:26-37. [3] Ma R, et al. Part Fibre Toxicol. 2020;17(1):50.
















